Favorable outcome without corticosteroids during post-artesunate delayed hemolysis with positive direct antiglobulin test in severe imported Plasmodium falciparum malaria, France

Favorable outcome without corticosteroids during post-artesunate delayed hemolysis with positive direct antiglobulin test in severe imported Plasmodium falciparum malaria, France

Objectives: Positive direct antiglobulin tests (DATs) have been reported in cases of post-artesunate delayed hemolysis (PADH), but the causal role of auto-immune hemolysis remains unclear. We aimed to analyze a cohort of patients with PADH and DAT during severe malaria.Methods: We describe PADH and...

Full description

Bibliographic Details
Main Authors:	Olivier Paccoud, Xavier Chamillard, Eric Kendjo, Isabelle Vinatier, Laure Surgers, Denis Magne, Benjamin Wyplosz, Adéla Angoulvant, Olivier Bouchaud, Arezki Izri, Sophie Matheron, Sandrine Houzé, Marc Thellier, Alioune P. Ndour, Pierre Buffet, Eric Caumes, Stéphane Jauréguiberry
Format:	Article
Language:	English
Published:	Elsevier 2023-12-01
Series:	International Journal of Infectious Diseases
Subjects:	Malaria Post-artesunate delayed hemolysis Direct antiglobulin test Artesunate
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971223007555

Similar Items

Positive direct antiglobulin test in post-artesunate delayed haemolysis: more than a coincidence?
by: Daniel Camprubí, et al.
Published: (2019-04-01)

Treatment for Severe Malaria: Post-Artesunate Delayed Haemolysis and Neutropenia
by: Mariangela Martino, et al.
Published: (2022-02-01)

Post-Artesunate Delayed Hemolysis: A Review of Current Evidence
by: Sawettachai Jaita, et al.
Published: (2023-01-01)

Tratamento da malária com artesunate (retocaps®) em crianças da Amazônia brasileira Malaria treatment with artesunate (retocaps®) in children of the Brazilian Amazon
by: Maria das Graças Costa Alecrim, et al.
Published: (2000-04-01)

Changes in the clinical presentation and outcomes of patients treated for severe malaria in a referral French university intensive care unit from 2004 to 2017
by: Jordane Lebut, et al.
Published: (2020-02-01)

Activities of artesunate-based combinations and tafenoquine against Babesia bovis in vitro and Babesia microti in vivo
by: Leonardo J. M. Carvalho, et al.
Published: (2020-07-01)

Systematic analysis of direct antiglobulin test results in post-artesunate delayed haemolysis
by: Tommaso Ascoli Bartoli, et al.
Published: (2021-04-01)

Pre-referral rectal artesunate is no “magic bullet” in weak health systems
by: Manuel W. Hetzel, et al.
Published: (2023-03-01)

Artesunate Suppresses the Proliferation and Development of Estrogen Receptor-α-Positive Endometrial Cancer in HAND2-Dependent Pathway
by: Xianghua Yin, et al.
Published: (2021-01-01)

Key factors predicting suspected severe malaria case management and health outcomes: an operational study in the Democratic Republic of the Congo
by: Jean Okitawutshu, et al.
Published: (2022-09-01)

Retinal safety and toxicity study of artesunate in vitro and in vivo
by: Bing-Wen Lu, et al.
Published: (2023-05-01)

The Other Face of Artesunate: Southern Drug to Treat Northern Diseases
by: Stephane Picot
Published: (2015-01-01)

Severe malaria in a Nigerian neonate and treatment with intravenous artesunate
by: Kelechi Kenneth Odinaka, et al.
Published: (2015-07-01)

Artesunate-induced hemolysis and hypoglycemia in rats: Gender implication and role of antioxidant enzymes
by: Mohammed T Salman, et al.
Published: (2017-01-01)

Synthesis and Characterization of Dimeric Artesunate Glycerol Monocaprylate Conjugate and Formulation of Nanoemulsion Preconcentrate
by: Rana Hore, et al.
Published: (2023-07-01)

Direct antiglobulin test positivity in multi-transfused thalassemics
by: Ashish Jain, et al.
Published: (2016-01-01)

Severe Delayed Hemolysis Associated with Regulated Parenteral Antimalarial Drug
by: Julia Lee, et al.
Published: (2015-01-01)

Artesunate Switches Monocytes to an Inflammatory Phenotype with the Ability to Kill Leukemic Cells
by: Rubia Isler Mancuso, et al.
Published: (2021-01-01)

Repurposing antimalarial artesunate for the prophylactic treatment of depression: Evidence from preclinical research
by: Shihao Huang, et al.
Published: (2023-01-01)

Therapeutic efficacy of artesunate in the treatment of uncomplicated <it>Plasmodium falciparum</it> malaria and anti-malarial, drug-resistance marker polymorphisms in populations near the China-Myanmar border
by: Huang Fang, et al.
Published: (2012-08-01)

Comparison of the efficacy of artemether-lumefantrine vs. artesunate plus sulfadoxine-pyrimethamine in children with uncomplicated falciparum malaria
by: Rachmawati Rachmawati, et al.
Published: (2010-04-01)

The Metabolic Changes of Artesunate and Ursolic Acid on Syrian Golden Hamsters Fed with the High-Fat Diet
by: Shichen Pu, et al.
Published: (2020-03-01)

Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial
by: Qi Chen, et al.
Published: (2022-05-01)

Artesunate, imatinib, and infliximab in COVID‐19: A rapid review and meta‐analysis of current evidence
by: Bahman Amani, et al.
Published: (2022-06-01)

Predictors of health workers’ knowledge about artesunate-based severe malaria treatment recommendations in government and faith-based hospitals in Kenya
by: Beatrice Machini, et al.
Published: (2020-07-01)

Artesunate-amodiaquine fixed dose combination for the treatment of <it>Plasmodium falciparum </it>malaria in India
by: Anvikar Anupkumar R, et al.
Published: (2012-03-01)

Artesunate-, sulfadoxine-, and pyrimethamine-induced cardiotoxicity
by: Divya Goel, et al.
Published: (2016-01-01)

Population pharmacokinetics and pharmacodynamics of the artesunate–mefloquine fixed dose combination for the treatment of uncomplicated falciparum malaria in African children
by: Monia Guidi, et al.
Published: (2019-04-01)

Assessment of parasite clearance following treatment of severe malaria with intravenous artesunate in Ugandan children enrolled in a randomized controlled clinical trial
by: Pauline Byakika-Kibwika, et al.
Published: (2018-10-01)

Artemisinin anti-malarial drugs in China
by: Zongru Guo
Published: (2016-03-01)

Safety and efficacy of four drug regimens versus standard-of-care for the treatment of symptomatic outpatients with COVID-19: A randomised, open-label, multi-arm, phase 2 clinical trialResearch in context
by: Nomathemba Chandiwana, et al.
Published: (2022-12-01)

Post-artesunate delayed hemolysis after treatment of malaria with intravenous artesunate: A case study
by: Abigail Foster
Published: (2022-01-01)

Role of direct antiglobulin test in assessing the severity of extravascular hemolysis in autoimmune hemolytic anemia – analysis from a cross-sectional study
by: Anjaly Padmavilas Sasikala, et al.
Published: (2023-03-01)

Antineoplastic Drug Synergy of Artesunate with Navitoclax in Models of High-Grade Serous Ovarian Cancer
by: J. Robert McCorkle, et al.
Published: (2024-03-01)

Meta-Analysis of Data from Four Clinical Trials in the Ivory Coast Assessing the Efficacy of Two Artemisinin-Based Combination Therapies (Artesunate-Amodiaquine and Artemether-Lumefantrine) between 2009 and 2016
by: Akoua Valérie Bédia-Tanoh, et al.
Published: (2023-12-01)

Therapeutic efficacy and safety of artesunate + amodiaquine and artemether + lumefantrine in treating uncomplicated Plasmodium falciparum malaria in children on the rainy south-east coast of Madagascar
by: Irinantenaina Judickaëlle, et al.
Published: (2023-01-01)

LC-MS/TOF Characterization and Stability Study of Artesunate in Different Solvent Systems
by: Kogila Oke, et al.
Published: (2022-08-01)

KEAP1 Is Required for Artesunate Anticancer Activity in Non-Small-Cell Lung Cancer
by: Kristen S. Hill, et al.
Published: (2021-04-01)

Efficacy and safety of pyronaridine-artesunate (Pyramax®) for the treatment of uncomplicated Plasmodium vivax malaria in Northwest Ethiopia
by: Hussein Mohammed, et al.
Published: (2022-12-01)

Artesunate: could be an alternative drug to chloroquine in COVID-19 treatment?
by: Tuğçenur Uzun, et al.
Published: (2020-05-01)